(NASDAQ: DCTH) Delcath Systems's forecast annual revenue growth rate of 26.46% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.13%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.39%.
Delcath Systems's revenue in 2026 is $85,231,000.On average, 9 Wall Street analysts forecast DCTH's revenue for 2026 to be $3,688,307,750, with the lowest DCTH revenue forecast at $3,415,341,705, and the highest DCTH revenue forecast at $4,038,896,777. On average, 9 Wall Street analysts forecast DCTH's revenue for 2027 to be $4,911,026,071, with the lowest DCTH revenue forecast at $4,123,677,473, and the highest DCTH revenue forecast at $6,112,201,755.
In 2028, DCTH is forecast to generate $5,960,013,456 in revenue, with the lowest revenue forecast at $4,671,972,304 and the highest revenue forecast at $7,584,745,160.